Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Gemini Therapeutics, Inc.

GMTX

HealthcareNASDAQUS

$1.35

$0.00 (+0.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

GMTX News

News and disclosures filtered by period, publisher, and event group.

1 / 1

Filter options

Period

From

Company only

Official only

Event search

Event group

Company announcementsFinancial reportsProspectus, capital raise, listingProfit distribution and paymentsPurchase offersLegal proceedingsTrading and market makerCompany detailsManagementSecurity termsCapital and holdersBoard decisions and meetingsInterested-party transactions

Results

Select a headline to open the full news page in the app.

May 27, 2026, 7:00 AMbusinesswire.comGMTX

Gemini Therapeutics Announces ASCO 2026 Analyses Supporting Aldoxorubicin's Tumor-Targeted Delivery and Cardiac-Safety Profile

Company announcements

SAN FRANCISCO--(BUSINESS WIRE)-- #ASCO--Gemini Therapeutics Announces ASCO 2026 Analyses Supporting Aldoxorubicin's Tumor-Targeted Delivery and Cardiac-Safety Profile.

Loading disclosure news